API |
Navê hilberê |
DOZA NO. |
Bisinifkirinî |
Canagliflozin |
2-(4-Fluorofenyl)-5-[(5-iodo-2-methylfenyl)methyl]thiophene |
898566-17-1 |
nexweşîya şekir |
Empagliflozin |
(3S)-3-[4-[(5-Bromo-2-klorofenîl)methyl]fenoksî]tetrahydro-furan |
915095-89-5 |
nexweşîya şekir |
Linagliptin |
8-bromo-7-(lê-2-ynîl)-3-methyl-1H-purine-2,6(3H,7H)-dion |
666816-98-4 |
nexweşîya şekir |
Linagliptin |
2-(chloromethyl)-4-methylquinazoline |
109113-72-6 |
nexweşîya şekir |
Linagliptin |
8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dion |
853029-57-9 |
nexweşîya şekir |
Saxagliptin |
(1S,3S,5S)-3-(Amînokarbonîl)-2-azabicîklo[3.1.0]hexane-2-karboksîlî asîda tert-butil ester |
361440-67-7 |
nexweşîya şekir |
Saxagliptin |
(alphaS)-alfa-[[(1,1-Dîmethyletoksî)karbonîl]amino]-3-hîdroksîtricîclo[3.3.1.13,7]dekan-1-asîda acetîk |
361442-00-4 |
nexweşîya şekir |
Sitagliptin |
2,4,5-Trifluorofenylacetic acid |
209995-38-0 |
nexweşîya şekir |
Sitagliptin |
Boc-(R)-3-Amino-4-(2,4,5-Trifluoro-Fenyl)-Butyric Acid |
486460-00-8 |
nexweşîya şekir |
Sitagliptin |
3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a] pîrazîn hîdrochloride |
762240-92-6 |
nexweşîya şekir |
Vildagliptin |
L-Prolinamide |
7531-52-4 |
nexweşîya şekir |
Vildagliptin |
(2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile |
207557-35-5 |
nexweşîya şekir |
Empagliflozin Dapagliflozin/Canagliflozin |
2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone |
32384-65-9 |
nexweşîya şekir |
Vildagliptin |
L-Prolinamide |
7531-52-4 |
nexweşîya şekir |
Liraglutide |
Liraglutide |
204656-20-2 |
nexweşîya şekir |
ABT-888 |
(S)-2-Methylproline |
42856-71-3 |
Dij-kanserê |
Docetaxel |
10-Deacetilbaccatin III |
32981-86-5 |
Dij-kanserê |
Lenvatinib |
4-chloro-7-methoxyquinoline-6-carboxamide |
417721-36-9 |
Dij-kanserê |
Lenvatinib |
4-Amino-3-chlorophenol hydrochloride |
52671-64-4 |
Dij-kanserê |
Acalabrutinib |
(3-Chloropyrazin-2-yl) MethanaMine hîdrochloride |
939412-86-9 |
Dij-kanserê |
Acalabrutinib |
N-Benzîloksîkarbonîl-L-prolîn |
1148-11-4 |
Dij-kanserê |
Acalabrutinib |
N-Pyridin-2-yl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide |
1383385-64-5 |
Dij-kanserê |
Acalabrutinib |
2-Asîda butînoîk |
590-93-2 |
Dij-kanserê |
Nilotinib |
3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline |
641571-11-1 |
Dij-kanserê |
Nilotinib |
Difenilfosforîl azid |
26386-88-9 |
Dij-kanserê |
Nilotinib |
4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid |
641569-94-0 |
Dij-kanserê |
Nilotinib |
1-(3-Pyridyl)-3-(dimetilamino)-2-propen-1-one |
55314-16-4 |
Dij-kanserê |
Abirterone Acetate |
17-Iodoandrosta-5,16-dien-3beta-ol |
32138-69-5 |
Dij-kanserê |
Abirterone Acetate |
17-Iodoandrosta-5,16-dien-3beta-ol 3-acetate |
114611-53-9 |
Dij-kanserê |
Neratinib |
3-chloro-4-(pyridin-2-ylmethoxy)aniline |
524955-09-7 |
Dij-kanserê |
Neratinib |
N-(4-Chloro-3-cyano-7-etoksî-6-quinolinyl)acetamide |
848133-76-6 |
Dij-kanserê |
Neratinib |
6-amino-4-(3-chloro-4-(pyridin-2-ylmethoxy)fenylamino)-7-etoksîquinoline-3-karbonitrile |
848139-78-6 |
Dij-kanserê |
Neratinib |
trans-4-Dimethylaminocrotonic acid hîdrochloride |
848133-35-7 |
Dij-kanserê |
Palbociclib |
tert-butyl 4-(6-amino-3-pyridyl)piperazine-1-carboxylate |
571188-59-5 |
Dij-kanserê |
Palbociclib |
6-Bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one |
1016636-76-2 |
Dij-kanserê |
Ribociclib |
2-Chloro-7-cyclopentyl-n,n-dimethyl-7h-pyrrolo[2,3d]pyrimidine-6-carboxamide |
1211443-61-6 |
Dij-kanserê |
Ribociclib |
2-Chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid |
1211443-58-1 |
Dij-kanserê |
Ceritinib / Crizotinib |
4-(4-Bromopyrazol-1-yl)piperidine-1-karboksîlî asîda tert-butil ester |
877399-50-3 |
Dij-kanserê |
Ceritinib / Crizotinib |
tert-Butyl 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]piperidine-1-carboxylate |
877399-74-1 |
Dij-kanserê |
Ceritinib / Crizotinib |
(S)-1-(2,6-Dîkloro-3-fluorofenîl)etanol |
877397-65-4;42247-74-5 |
Dij-kanserê |